Derville O’Shea

1.8k total citations
19 papers, 709 citations indexed

About

Derville O’Shea is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Derville O’Shea has authored 19 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Derville O’Shea's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Derville O’Shea is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Derville O’Shea collaborates with scholars based in United Kingdom, Ireland and Germany. Derville O’Shea's co-authors include Penny J. Hunt, David R. Cole, Tom Cawood, S. Soule, Eduardo Olavarría, Jane F. Apperley, John M. Goldman, T. Andrew Lister, Jude Fitzgibbon and Jolanta B. Perz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Derville O’Shea

18 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derville O’Shea United Kingdom 9 272 206 191 187 186 19 709
Max M. van Noesel Netherlands 16 137 0.5× 133 0.6× 68 0.4× 125 0.7× 33 0.2× 44 1.0k
Hirotaka Takasaki Japan 16 153 0.6× 50 0.2× 148 0.8× 317 1.7× 83 0.4× 59 732
Rachel L. Sargent United States 15 240 0.9× 79 0.4× 471 2.5× 434 2.3× 26 0.1× 39 851
Markus Mayrhofer Sweden 12 47 0.2× 105 0.5× 35 0.2× 78 0.4× 108 0.6× 21 506
Martin J. Magers United States 15 55 0.2× 493 2.4× 44 0.2× 78 0.4× 44 0.2× 26 948
Yeşim Ertan Türkiye 13 26 0.1× 142 0.7× 66 0.3× 88 0.5× 150 0.8× 67 469
S. Molica Italy 11 143 0.5× 81 0.4× 187 1.0× 286 1.5× 15 0.1× 26 545
Mani Akhtari United States 8 60 0.2× 120 0.6× 43 0.2× 150 0.8× 33 0.2× 21 611
Charles Allam Lebanon 13 246 0.9× 166 0.8× 69 0.4× 181 1.0× 28 0.2× 24 746
Maria Stefania Lagonigro Italy 10 42 0.2× 187 0.9× 35 0.2× 38 0.2× 81 0.4× 13 679

Countries citing papers authored by Derville O’Shea

Since Specialization
Citations

This map shows the geographic impact of Derville O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derville O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derville O’Shea more than expected).

Fields of papers citing papers by Derville O’Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derville O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derville O’Shea. The network helps show where Derville O’Shea may publish in the future.

Co-authorship network of co-authors of Derville O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Derville O’Shea. A scholar is included among the top collaborators of Derville O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derville O’Shea. Derville O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
O’Connor, Mairead, et al.. (2023). Experiences of and preferences for self-management among low grade non-Hodgkin's lymphoma survivors: A qualitative interview study. European Journal of Oncology Nursing. 66. 102378–102378. 1 indexed citations
2.
Crampe, Mireille, et al.. (2019). Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3BCR-ABL1Fusion. SHILAP Revista de lepidopterología. 2019. 1–4. 2 indexed citations
3.
Hayes, Brian, et al.. (2018). A Stab in the Back: An Unusual Case of Cutaneous Neural Infiltration as a Manifestation of Chronic Lymphoproliferative Disorder of Natural Killer Cells. American Journal of Dermatopathology. 41(5). 378–381. 1 indexed citations
4.
Crampe, Mireille, Karl Haslam, Emma M. Groarke, et al.. (2017). Chronic Myeloid Leukemia with an e6a2BCR-ABL1Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring. SHILAP Revista de lepidopterología. 2017. 1–5. 2 indexed citations
5.
Haslam, Karl, Eibhlin Conneally, Catherine Flynn, et al.. (2016). CALR mutation profile in Irish patients with myeloproliferative neoplasms. Hematology/Oncology and Stem Cell Therapy. 9(3). 112–115. 2 indexed citations
6.
Crowley, Maeve P., Siobhán O’Neill, Barry Kevane, et al.. (2015). Ionizing radiation exposure as a result of diagnostic imaging in patients with lymphoma. Clinical & Translational Oncology. 18(5). 533–536. 6 indexed citations
7.
Crowley, Maeve P., Siobhán O’Neill, Brian Bird, et al.. (2013). Radiation Exposure From Diagnostic Imaging in Patients with Lymphoma - The Cost Of The Cure?. Blood. 122(21). 557–557.
8.
Cawood, Tom, Penny J. Hunt, Derville O’Shea, David R. Cole, & S. Soule. (2009). Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?. European Journal of Endocrinology. 161(4). 513–527. 215 indexed citations
9.
O’Shea, Derville, Ciarán Ó’Riain, Manu Gupta, et al.. (2009). Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood. 113(10). 2298–2301. 49 indexed citations
10.
O’Shea, Derville, Ciarán Ó’Riain, Claire Taylor, et al.. (2008). The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood. 112(8). 3126–3129. 87 indexed citations
11.
Brodie, Chaya, Shruti Agrawal, Amin Rahemtulla, et al.. (2007). Multiple myeloma with bone marrow extracellular crystal deposition: Figure 1. Journal of Clinical Pathology. 60(9). 1064–1065. 3 indexed citations
12.
Fitzgibbon, Jude, Sameena Iqbal, Andrew Davies, et al.. (2007). Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia. 21(7). 1514–1520. 55 indexed citations
13.
Perz, Jolanta B., Richard Szydlo, Ruhena Sergeant, et al.. (2007). Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab. Transplant Immunology. 18(2). 179–185. 4 indexed citations
14.
Carlotti, Emanuela, David Wrench, Sameena Iqbal, et al.. (2007). Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma.. Blood. 110(11). 181–181. 1 indexed citations
15.
Olavarría, Eduardo, Shamyla Siddique, Mike Griffiths, et al.. (2007). Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia. Blood. 110(13). 4614–4617. 70 indexed citations
16.
Perz, Jolanta B., Chrissy Giles, Richard Szydlo, et al.. (2006). LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplantation. 39(1). 41–47. 14 indexed citations
17.
O’Shea, Derville, Chrissy Giles, Evangelos Terpos, et al.. (2006). Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplantation. 37(8). 731–737. 89 indexed citations
19.
Kong, W. M., et al.. (1999). The Midnight to Morning Urinary Cortisol Increment Is an Accurate, Noninvasive Method for Assessment of the Hypothalamic-Pituitary-Adrenal Axis. The Journal of Clinical Endocrinology & Metabolism. 84(9). 3093–3098. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026